Sort
25,944 grants matching “neurodegeneration”
ALZHEIMER DISEASE RESEARCH CENTER
$1,444,639University Of Southern California · P50 · FY2002 · AG
Cyclin-dependent kinase 5 (Cdk5 physiology and pathology)
$1,444,594Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
The Emory Alzheimer's Disease Center
$1,444,388Allan I Levey · Emory University · P50 · FY2006 · AG
Exercise for Brain Health with Increased Genetic Risk for Alzheimer's Disease
$1,444,213Jerome Carson Smith · Univ Of Maryland, College Park · R01 · FY2021 · AG
Reactive Oxygen Species and Aging
$1,442,330Elias K Michaelis · University Of Kansas Lawrence · P01 · FY2008 · AG
Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study
$1,442,176Keith M Diaz · Columbia University Health Sciences · R01 · FY2024 · AG
Immunophilin ligands for HIV dementia and neuropathy
$1,441,957Johns Hopkins University · P01 · FY2004 · MH
Early and life course socioeconomic adversity and dementia risk in Hispanics/Latinos
$1,441,831Carmen R Isasi · Albert Einstein College Of Medicine · RF1 · FY2022 · AG
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging
$1,441,351Ann Carolyn McKee · Boston University Medical Campus · U01 · FY2017 · NS
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$1,440,686Nigel H. Greig · National Institute On Aging · ZIA · FY2025 · AG
Uncovering the role of extracellular condensates as triggers of neuroinflammation
$1,440,000Steven Boeynaems · Baylor College Of Medicine · DP2 · FY2024 · NS
The Emory Alzheimer's Disease Center
$1,438,905Allan I Levey · Emory University · P50 · FY2007 · AG
Study of Brain Spreading Pathways of Tau and Amyloid-Beta in (pre)clinical AD
$1,438,308Quanzheng Li · Massachusetts General Hospital · RF1 · FY2017 · AG
Regional, Synaptic, Cellular Modulation of Abeta Metabolism
$1,437,764David M Holtzman · Washington University · P01 · FY2020 · NS
Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease
$1,437,570Jagdish Singh · North Dakota State University · RF1 · FY2021 · AG
1Florida Alzheimer's Disease Research Center Clinical Core
$1,437,141Melissa Jo Armstrong · University Of Florida · P30 · FY2024 · AG
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,435,400Matthew D Disney · Scripps Florida · P01 · FY2019 · NS
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,435,400Matthew D Disney · Scripps Florida · P01 · FY2018 · NS
Regulation Of Intracellular Iron Metabolism
$1,435,381Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Gene Therapy for Batten Disease
$1,435,327Weill Medical College Of Cornell Univ · U01 · FY2005 · NS
DNA Damage and Neurodegeneration in the Aging Brain
$1,434,833Bruce A Yankner · Harvard Medical School · P01 · FY2007 · AG
Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU
$1,433,652Vladislav Bergo · Adeptrix Corporation · R44 · FY2023 · AG
Role of Rab27b in synucleinopathies
$1,433,631Talene Alene Yacoubian · University Of Alabama At Birmingham · RF1 · FY2021 · NS
Studies of Hereditary Neurological Disease: Disease Mechanisms
$1,431,477Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Gene Therapy for Batten Disease
$1,431,192Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2006 · NS